Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis

被引:64
|
作者
Rabinovitch, Mark [2 ]
Bechard-Evans, Laura [3 ]
Schmitz, Norbert [2 ]
Joober, Ridha [2 ]
Malla, Ashok [1 ]
机构
[1] Douglas Mental Hlth Univ Inst, Div Clin Res, Montreal, PQ H4H 1R3, Canada
[2] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, PEPP Montreal, Douglas Hosp, Res Ctr, Montreal, PQ, Canada
关键词
treatment adherence; first-episode psychosis; social support; 1ST EPISODE PSYCHOSIS; SCHIZOAFFECTIVE DISORDER; MEDICATION ADHERENCE; UNTREATED PSYCHOSIS; RATING-SCALE; FOLLOW-UP; SCHIZOPHRENIA; DURATION; ILLNESS; NONCOMPLIANCE;
D O I
10.1177/070674370905400106
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the hypothesis that poorer social and family support, identifiable at the onset of treatment, is associated with nonadherence in the first 6 months of treatment of patients with first-episode psychosis (FEP), independent of other patient-related factors. Method: Consecutive patients (n = 100) admitted to a specialized early intervention service for FEP who met the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for either a schizophrenia spectrum disorder or an affective psychosis were evaluated monthly for 6 months regarding their adherence to medications. Using sociodernographic and illness-related factors, including social and family support, as independent variables and adherence as the dependent variable, univariate analyses were followed by logistic regression. Results: Fifty-six patients (54.9%) were adherent (76% to 100% of doses taken) and 46 (45.1%) nonadherent (less than 76% of doses taken). Nonadherent patients were less likely to have Support (chi(2) = 5.89, df= 1, P = 0.02), as rated by their respective received a good level of social I case manager, and more likely to be single (Fisher exact test, P = 0.019) and to have refused medication at the first offer of treatment (chi(2) = 19.70, df=1, P = 0.001). Using logistic regression, both the level of social support (OR = 3.552, P = 0.03) and early medication acceptance (OR = 11.092, P < 0.001) were significant as predictors of adherence. Conclusion: These results suggest the significance of social and family support in achieving adherence to medications very early in the course of treatment of FEP, in addition to the influence of early acceptance or rejection of medication.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [21] Predictors of Functional and Clinical Outcome in Early-Onset First-Episode Psychosis: The Child and Adolescent First Episode of Psychosis (CAFEPS) Study
    Parellada, Mara
    Castro-Fornieles, Josefina
    Gonzalez-Pinto, Ana
    Pina-Camacho, Laura
    Moreno, Dolores
    Rapado-Castro, Marta
    Otero, Soraya
    de la Serna, Elena
    Moreno, Carmen
    Baeza, Inmaculada
    Graell, Montserrat
    Arango, Celso
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (11) : E1441 - +
  • [22] EARLY INTERVENTION IN PSYCHOSIS First-Episode Psychosis and Critical Period
    Coentre, Ricardo
    Levy, Pedro
    Figueira, Maria Luisa
    [J]. ACTA MEDICA PORTUGUESA, 2011, 24 (01): : 117 - 126
  • [23] Discontinuation of antipsychotic medication following symptom remission in first-episode psychosis: views of UK Early Psychosis clinicians
    Thompson, Andrew
    Singh, Swaran
    Birchwood, Maximillian
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 142 - 142
  • [24] Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis
    Catalan, Ana
    Garcia, Lorena
    Sanchez-Alonso, Sergio
    Gil, Patxi
    Diaz-Marsa, Marina
    Manuel Olivares, Jose
    Rivera-Baltanas, Tania
    Perez-Martin, Jorge
    Gonzalez Torres, Miguel Angel
    Ovejero, Santiago
    Tost, Meritxell
    Berge, Daniel
    Rodriguez, Alfonso
    Labad, Javier
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (06) : 1584 - 1594
  • [25] Early response to antipsychotic medication in adolescents with first-episode psychosis predictor of ultimate response and remission
    Von Hardenberg, L.
    Correll, C. U.
    Galling, B.
    Pagsberg, K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S421 - S422
  • [26] ALLOSTATIC LOAD IS ASSOCIATED WITH POSITIVE SYMPTOMS IN SCHIZOPHRENIA AND FIRST-EPISODE PSYCHOSIS AND DECREASES WITH ANTIPSYCHOTIC THERAPY
    Berger, Maximus
    Juster, Robert-Paul
    Westphal, Sabine
    Amminger, G. Paul
    Steiner, Johann
    Sarnyai, Zoltan
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 : S9 - S10
  • [27] White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
    Szeszko, Philip R.
    Robinson, Delbert G.
    Ikuta, Toshikazu
    Peters, Bart D.
    Gallego, Juan A.
    Kane, John
    Malhotra, Anil K.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (06) : 1324 - 1331
  • [28] Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
    Ottesen, Akiah
    Hegelstad, W. T., V
    Joa, Inge
    Opjordsmoen, Stein E.
    Rund, Bjorn Rishovd
    Rossberg, Jan Ivar
    Simonsen, Erik
    Johannessen, Jan Olav
    Larsen, Tor K.
    Haahr, Ulrik Helt
    McGlashan, Thomas H.
    Friis, Svein
    Melle, Ingrid
    [J]. PSYCHOLOGICAL MEDICINE, 2023, 53 (06) : 2399 - 2408
  • [29] Spontaneous parkinsonism in antipsychotic-naive patients with first-episode psychosis
    Chong, SA
    Subramaniam, M
    Verma, S
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (07): : 429 - 431
  • [30] Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
    Mantere, Outi
    Trontti, Kalevi
    Garcia-Gonzalez, Judit
    Balcells, Ingrid
    Saarnio, Suvi
    Mantyla, Teemu
    Lindgren, Maija
    Kieseppa, Tuula
    Raij, Tuukka
    Honkanen, Jarno K.
    Vaarala, Outi
    Hovatta, Iiris
    Suvisaari, Jaana
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 109 : 18 - 26